Summit Therapeutics (SMMT) Gross Profit (2017 - 2020)
Summit Therapeutics' (SMMT) quarterly Gross Profit came in at -$7.6 million in Q1 2020, up 4.49% YoY from -$7.3 million in Q2 2019, and up 82.56% on a QoQ basis from -$43.6 million in Q4 2019.
Summit Therapeutics (SMMT) Gross Profit (2017 - 2020) Analysis & Trends
Summit Therapeutics (SMMT) has 4 years of Gross Profit data on file, last reported at -$7.6 million in Q1 2020.
- Quarterly Gross Profit rose 4.49% year-over-year to -$7.6 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$68.5 million (down 2172.18% YoY) and the FY2019 annual result came in at -$32.6 million, changed N/A from the prior year.
- Gross Profit grew to -$7.6 million in Q1 2020, from -$43.6 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $32.6 million in Q3 2018 to a low of -$43.6 million in Q4 2019.
- A 4-year average of -$8.3 million and a median of -$7.9 million in 2019 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2018 — Gross Profit jumped 681.99% — and 2019, when it sank 123.93%.
- Tracing SMMT's Gross Profit over 4 years: stood at -$6.8 million in 2017, then plunged by 77.57% to -$12.1 million in 2018, then sank by 258.84% to -$43.6 million in 2019, then soared by 82.56% to -$7.6 million in 2020.
- The last three Gross Profit figures came in at -$7.6 million (Q1 2020), -$43.6 million (Q4 2019), and -$9.5 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -7.60 Mn |
| Mar 31, 2020 | -7.60 Mn |
| Dec 31, 2019 | -43.56 Mn |
| Dec 31, 2019 | -43.56 Mn |
| Oct 31, 2019 | -9.52 Mn |
| Oct 31, 2019 | -9.52 Mn |
| Jul 31, 2019 | -7.81 Mn |
| Jul 31, 2019 | -7.81 Mn |
| Mar 31, 2019 | -7.96 Mn |
| Mar 31, 2019 | -7.96 Mn |
| Oct 31, 2018 | -12.14 Mn |
| Oct 31, 2018 | -12.14 Mn |
| Jul 31, 2018 | 32.64 Mn |
| Jul 31, 2018 | 32.64 Mn |
| Apr 30, 2018 | -9.24 Mn |
| Apr 30, 2018 | -9.24 Mn |
| Jan 31, 2018 | -14.21 Mn |
| Jan 31, 2018 | -14.21 Mn |
| Oct 31, 2017 | -6.84 Mn |
| Oct 31, 2017 | -6.84 Mn |